BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...expand its R&D team and construct a biochemical laboratory for internal compound testing. BC Staff ImmunoChina Eccogene Aegicare (Shenzhen) Technology Inhibikase Aivita Biomedical Suzhou...
BioCentury | Nov 21, 2020
Product Development

Nov. 20 Quick Takes: uniQure hemophilia therapy hits pivotal endpoint; plus data from Gilead in HIV, Aivita  in GBM and a setback for Poxel

...at the Society for the Immunotherapy of Cancer (SITC) meeting.TARGETSmPTP - Mitochondrial permeability transition pore BC Staff uniQure Aivita Biomedical Gilead Poxel...
BioCentury | Aug 20, 2018
Company News

Management tracks: Athenex, Intra-Cellular

...medical director of orthopedic clinical development at Ferring Pharmaceuticals A/S (Saint-Prex, Switzerland). Cellular therapy company Aivita Biomedical Inc....
BioCentury | Jun 15, 2018
Financial News

Aivita raises $15M series B, considers Korean clinical trial for cancer therapy

...Cellular therapy company Aivita Biomedical Inc. (Irvine, Calif.) raised $15 million on June 11 in a series B...
...considering beginning a Korean Phase II trial in an undisclosed tumor type. Aivita Biomedical Inc., Irvine, Calif. Jennie Walters AVOVA-1 AiVita Biomedical Inc....
BioCentury | Jun 20, 2016
Financial News

AiVita Biomedical completes venture financing

AiVita Biomedical Inc. , Irvine, Calif. Business: Gene/Cell therapy, Dermatology, Cancer Date completed: 2016-06-10 Type: Venture financing Raised: $2 million Investor: California Technology Ventures WIR Staff cancer Dermatology...
BioCentury | Jun 6, 2016
Company News

Caladrius Biosciences, AiVita Biomedical deal

...California. The companies declined to disclose financial terms. Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. AiVita Biomedical Inc....
Items per page:
1 - 6 of 6
BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...expand its R&D team and construct a biochemical laboratory for internal compound testing. BC Staff ImmunoChina Eccogene Aegicare (Shenzhen) Technology Inhibikase Aivita Biomedical Suzhou...
BioCentury | Nov 21, 2020
Product Development

Nov. 20 Quick Takes: uniQure hemophilia therapy hits pivotal endpoint; plus data from Gilead in HIV, Aivita  in GBM and a setback for Poxel

...at the Society for the Immunotherapy of Cancer (SITC) meeting.TARGETSmPTP - Mitochondrial permeability transition pore BC Staff uniQure Aivita Biomedical Gilead Poxel...
BioCentury | Aug 20, 2018
Company News

Management tracks: Athenex, Intra-Cellular

...medical director of orthopedic clinical development at Ferring Pharmaceuticals A/S (Saint-Prex, Switzerland). Cellular therapy company Aivita Biomedical Inc....
BioCentury | Jun 15, 2018
Financial News

Aivita raises $15M series B, considers Korean clinical trial for cancer therapy

...Cellular therapy company Aivita Biomedical Inc. (Irvine, Calif.) raised $15 million on June 11 in a series B...
...considering beginning a Korean Phase II trial in an undisclosed tumor type. Aivita Biomedical Inc., Irvine, Calif. Jennie Walters AVOVA-1 AiVita Biomedical Inc....
BioCentury | Jun 20, 2016
Financial News

AiVita Biomedical completes venture financing

AiVita Biomedical Inc. , Irvine, Calif. Business: Gene/Cell therapy, Dermatology, Cancer Date completed: 2016-06-10 Type: Venture financing Raised: $2 million Investor: California Technology Ventures WIR Staff cancer Dermatology...
BioCentury | Jun 6, 2016
Company News

Caladrius Biosciences, AiVita Biomedical deal

...California. The companies declined to disclose financial terms. Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. AiVita Biomedical Inc....
Items per page:
1 - 6 of 6